Detailed information for compound 234222

Basic information

Technical information
  • TDR Targets ID: 234222
  • Name: 1-cyclopropyl-6-fluoro-7-[(2R,3S)-3-hydroxy-2 -methylazetidin-1-yl]-4-oxoquinoline-3-carbox ylic acid
  • MW: 332.326 | Formula: C17H17FN2O4
  • H donors: 2 H acceptors: 4 LogP: 2.35 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O[C@H]1CN([C@@H]1C)c1cc2c(cc1F)c(=O)c(cn2C1CC1)C(=O)O
  • InChi: 1S/C17H17FN2O4/c1-8-15(21)7-19(8)14-5-13-10(4-12(14)18)16(22)11(17(23)24)6-20(13)9-2-3-9/h4-6,8-9,15,21H,2-3,7H2,1H3,(H,23,24)/t8-,15+/m1/s1
  • InChiKey: FGMMTZVNYCHRAY-GLEZIHRCSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-cyclopropyl-6-fluoro-7-[(2R,3S)-3-hydroxy-2-methyl-azetidin-1-yl]-4-oxo-quinoline-3-carboxylic acid
  • 1-cyclopropyl-6-fluoro-7-[(2R,3S)-3-hydroxy-2-methyl-1-azetidinyl]-4-oxo-3-quinolinecarboxylic acid
  • 1-cyclopropyl-6-fluoro-7-[(2R,3S)-3-hydroxy-2-methyl-azetidin-1-yl]-4-keto-quinoline-3-carboxylic acid

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Giardia lamblia Kinase, NEK 0.0213 1 1
Trichomonas vaginalis cyclin B, putative 0.0067 0.2008 0.1685
Plasmodium vivax NIMA-related protein kinase (Pfnek-1), putative 0.0213 1 1
Giardia lamblia Kinase, NEK 0.0213 1 1
Giardia lamblia G2/mitotic-specific cyclin B 0.0067 0.2008 0.1574
Trichomonas vaginalis cyclin B, putative 0.0067 0.2008 0.1685
Loa Loa (eye worm) hypothetical protein 0.0047 0.0947 0.2896
Echinococcus multilocularis cyclin dependent kinase 1 0.0049 0.1045 0.3552
Brugia malayi Cyclin, N-terminal domain containing protein 0.0067 0.2008 1
Schistosoma mansoni serine/threonine protein kinase 0.0049 0.1045 0.3552
Loa Loa (eye worm) CMGC/CDK/CDC2 protein kinase 0.0049 0.1045 0.3552
Trichomonas vaginalis cyclins, putative 0.0067 0.2008 0.1685
Trichomonas vaginalis cyclin D, putative 0.0039 0.0515 0.0131
Loa Loa (eye worm) hypothetical protein 0.0067 0.2008 1
Plasmodium falciparum NIMA related kinase 1 0.0213 1 1
Brugia malayi Cyclin, N-terminal domain containing protein 0.0067 0.2008 1
Trichomonas vaginalis STE family protein kinase 0.0213 1 1
Toxoplasma gondii NIMA-related protein kinase NIMA1 0.0213 1 1
Trichomonas vaginalis cyclin B3, putative 0.0039 0.0515 0.0131
Toxoplasma gondii cell-cycle-associated protein kinase CDK, putative 0.0049 0.1045 0.1045
Trypanosoma cruzi cyclin, putative 0.0067 0.2008 1
Trichomonas vaginalis AGC family protein kinase 0.0213 1 1
Echinococcus multilocularis cyclin dependent kinase 1 0.0049 0.1045 0.3552
Trypanosoma cruzi cyclin, putative 0.0067 0.2008 1
Echinococcus granulosus 5'partial|cyclin dependent kinase 1 0.0049 0.1045 0.3552
Brugia malayi Protein kinase domain containing protein 0.0049 0.1045 0.3552
Trichomonas vaginalis cyclin B, putative 0.0067 0.2008 0.1685
Trichomonas vaginalis cyclin D, putative 0.0039 0.0515 0.0131
Echinococcus granulosus cyclin dependent kinase 1 0.0049 0.1045 0.3552
Echinococcus granulosus cyclin dependent kinase 5 0.0049 0.1045 0.3552
Trichomonas vaginalis cyclins, putative 0.0067 0.2008 0.1685
Giardia lamblia Kinase, CMGC CDK 0.0049 0.1045 0.0559
Giardia lamblia Kinase, CMGC CDK 0.0049 0.1045 0.0559
Trichomonas vaginalis cyclins, putative 0.0039 0.0515 0.0131
Trichomonas vaginalis cyclins, putative 0.0067 0.2008 0.1685
Echinococcus multilocularis cyclin dependent kinase 5 0.0049 0.1045 0.3552
Trichomonas vaginalis CMGC family protein kinase 0.0049 0.1045 0.0683
Echinococcus multilocularis cyclin dependent kinase 0.0049 0.1045 0.3552
Trypanosoma cruzi cyclin 6, putative 0.0067 0.2008 1
Leishmania major cyclin 0.0067 0.2008 1
Entamoeba histolytica cell division protein kinase 2, putative 0.0049 0.1045 0.3552
Trichomonas vaginalis cyclin B, putative 0.0067 0.2008 0.1685
Echinococcus multilocularis cyclin B 0.0067 0.2008 1
Trypanosoma brucei mitotic cyclin 6 0.0067 0.2008 1
Onchocerca volvulus 0.0067 0.2008 0.5
Leishmania major CYC2-like cyclin, putative,cyclin 6, putative 0.0067 0.2008 1
Trichomonas vaginalis cyclin A, putative 0.0067 0.2008 0.1685
Brugia malayi cell division control protein 2 homolog 0.0049 0.1045 0.3552
Schistosoma mansoni cyclin B 0.0067 0.2008 1
Trichomonas vaginalis CMGC family protein kinase 0.0049 0.1045 0.0683
Trichomonas vaginalis CMGC family protein kinase 0.0049 0.1045 0.0683
Loa Loa (eye worm) CMGC/CDK/CDC2 protein kinase 0.0049 0.1045 0.3552
Trichomonas vaginalis cyclin B, putative 0.0039 0.0515 0.0131
Echinococcus granulosus cyclin dependent kinase 0.0049 0.1045 0.3552
Plasmodium falciparum protein kinase 5 0.0049 0.1045 0.0559
Trichomonas vaginalis cyclins, putative 0.0067 0.2008 0.1685
Entamoeba histolytica cell division protein kinase 2, putative 0.0049 0.1045 0.3552
Schistosoma mansoni serine/threonine protein kinase 0.0049 0.1045 0.3552
Loa Loa (eye worm) CMGC/CDK/CDK5 protein kinase 0.0049 0.1045 0.3552
Trypanosoma cruzi CYC2-like cyclin, putative 0.0067 0.2008 1
Entamoeba histolytica cyclin, putative 0.0067 0.2008 1
Trichomonas vaginalis conserved hypothetical protein 0.0039 0.0515 0.0131
Loa Loa (eye worm) hypothetical protein 0.0067 0.2008 1
Echinococcus granulosus cyclin B 0.0067 0.2008 1

Activities

Activity type Activity value Assay description Source Reference
Log k' (ADMET) = 0.4068 HPLC capacity factor (k') ChEMBL. 7990118
MIC (functional) = 0.015 ug ml-1 In vitro minimum inhibitory concentration for Bacillus subtilis ATCC 6633 ChEMBL. 7990118
MIC (functional) = 0.015 ug ml-1 In vitro minimum inhibitory concentration to inhibit Klebsiella pneumoniae ATCC 10031 ChEMBL. 7990118
MIC (functional) = 0.06 ug ml-1 In vitro minimum inhibitory concentration for Bacillus cereus ATCC 11778 ChEMBL. 7990118
MIC (functional) = 0.06 ug ml-1 In vitro minimum inhibitory concentration for Staphylococcus epidermidis ATCC 155-1 ChEMBL. 7990118
MIC (functional) = 0.06 ug ml-1 In vitro minimum inhibitory concentration for Proteus vulgaris ATCC 8427 ChEMBL. 7990118
MIC (functional) = 0.12 ug ml-1 In vitro minimum inhibitory concentration for Staphylococcus aureus ATCC 25178 ChEMBL. 7990118
MIC (functional) = 0.12 ug ml-1 In vitro minimum inhibitory concentration for Enterobacter cloacae ATCC 23355 ChEMBL. 7990118
MIC (functional) = 0.25 ug ml-1 In vitro minimum inhibitory concentration for Morganella morganii ATCC 8019 ChEMBL. 7990118
MIC (functional) = 0.25 ug ml-1 In vitro minimum inhibitory concentration for Escherichia coli ATCC 10799 ChEMBL. 7990118
MIC (functional) = 0.25 ug ml-1 In vitro minimum inhibitory concentration for Escherichia coli ATCC 10799 ChEMBL. 7990118
MIC (functional) = 2 ug ml-1 In vitro minimum inhibitory concentration for Streptococcus faecalis ATCC 10541 ChEMBL. 7990118
MIC (functional) = 2 ug ml-1 In vitro minimum inhibitory concentration for Pseudomonas aeruginosa ATCC 10145 ChEMBL. 7990118

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.